Literature DB >> 7406638

[Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].

R Girot, M Thévenin, J P Bouveret, F Jeannel, J C Rymer.   

Abstract

The urinary excretion of iron has been studied in 23 cases of iron overload (20 thalassemia major, 2 pure red cell aplasia, 1 congenital sideroblastic anemia) after 12 hour subcutaneous infusions of 0.5 g, 1 g, 2 g and 3 g of desferrioxamine (D). The urinary excretion of iron was correlated with the dose of D and the serum ferritin. Continuous subcutaneous infusion of 0.5 g and 1 g D over 12 hours increased the mean urinary iron excretion from 6.6 to 12 mg/day and 9.9 to 18 mg/day respectively compared with intramuscular injection of a similar dose. The test doses of D have been used to determine the dose of D necessary to balance the iron received in transfusion and the iron excreted in the urine. Five children treated for between 7 and 12 months demonstrated that the treatment is effective. Serum ferritin levels decreased and the children were in negative iron balance. Using a portable constant infusion pump subcutaneous infusions can be given at home.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406638

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  2 in total

1.  Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis.

Authors:  Soo-Jeong Park; Chi-Wha Han
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

2.  Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children.

Authors:  E A Llados i Vallory; R Girot; G Lenoir; M Payet; P Houze; R Bourdon
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.